Search

everythinglearnresearchcommunity

for

Search:↓

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Cedrol may be an effective treatment for colorectal cancer.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Some drugs can cause permanent hair loss, though it's rare.

More effective methods are needed to prevent hair loss from chemotherapy.

Skin cancer in sun-exposed areas is more likely to come back.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.